High Coffee Intake Lowers Risk of Prostate Cancer Recurrence

This article originally appeared here.
Share this content:
Pre-Diagnosis Coffee Intake Tied to Prostate CA Outcomes
Pre-Diagnosis Coffee Intake Tied to Prostate CA Outcomes

(HealthDay News) -- Higher coffee consumption before prostate cancer diagnosis is associated with a lower risk of recurrence/progression, according to a study published in the August issue of Cancer Causes & Control.

To examine the correlation between pre-diagnostic coffee and tea consumption and the risk of prostate cancer recurrence/progression, Milan S. Geybels, from Maastricht University in the Netherlands, and colleagues assessed the usual pattern of coffee and tea consumption in men diagnosed with prostate cancer (2002 to 2005) for two years before the date of diagnosis.

The researchers included 630 patients with a median follow-up of 6.4 years, during which time there were 140 recorded prostate cancer recurrence/progression events. About 61 percent of patients reported intake of one or more cups of coffee per day. The risk of prostate cancer recurrence/progression was significantly lower with coffee consumption (adjusted hazard ratio for at least four cups/day versus no more than one cup/week, 0.41). About 14 percent of patients consumed at least one cup of tea per day, but there was no correlation seen between tea consumption and prostate cancer recurrence/progression.

"Results indicate that higher pre-diagnostic coffee consumption is associated with a lower risk of prostate cancer recurrence/progression," the authors write. "This finding will require replication in larger studies."

Full Text (subscription or payment may be required)

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs